Sesen Bio logo
Sesen Bio SESN

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Sesen Bio DSO Ratio 2011-2026 | SESN

Annual DSO Ratio Sesen Bio

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 391 144 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
391 144 268

Quarterly DSO Ratio Sesen Bio

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - 1.29 18.3 1.22 K - - 488 30.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.22 K 1.29 352

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 330.34 3.6 % $ 43.3 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
9.68 $ 0.44 -16.64 % $ 5.04 M israelIsrael
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
59.5 $ 24.98 1.17 % $ 3.05 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
239 $ 10.14 -0.29 % $ 135 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.58 - $ 106 M usaUSA
Curis Curis
CRIS
103 $ 0.53 -3.07 % $ 6.98 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
211 $ 37.7 1.26 % $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 49.15 -0.73 % $ 4.42 B schweizSchweiz
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.3 $ 4.4 -3.51 % $ 607 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Cue Biopharma Cue Biopharma
CUE
43.1 $ 0.18 -1.61 % $ 17.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.09 -0.97 % $ 437 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
120 $ 4.15 -32.52 % $ 10.4 M usaUSA
Daré Bioscience Daré Bioscience
DARE
877 $ 1.81 4.02 % $ 20.2 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
71.3 $ 20.36 -3.32 % $ 2.84 B franceFrance
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.22 2.37 % $ 225 M israelIsrael
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
1.89 $ 19.38 -6.15 % $ 3.19 B usaUSA
Dyadic International Dyadic International
DYAI
78.4 $ 0.87 -2.8 % $ 31.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 31.37 1.0 % $ 2.08 B usaUSA